Jim Cramer says ‘exhausted’ sellers are behind the market’s strength

Jim Cramer says ‘exhausted’ sellers are behind the market’s strength


CNBC’s Jim Cramer said on Thursday that stocks have largely stayed resilient lately because the investors remaining in the market are there to stay.

“The sellers are exhausted. The remaining shareholders, they may just be in it for the long haul. That’s why so much money’s in index funds. People don’t want to trade. They just want to own and own and own some more,” he said.

Stocks closed down on Thursday but managed to rebound from lows reached earlier in the day after St. Louis Federal President James Bullard said in a speech that the central bank hasn’t sufficiently tamped down inflation.

The Dow Jones Industrial Average fell 7.51 points, or 0.02%, after tumbling as much as 314 points during the trading session. The S&P 500 and Nasdaq Composite slipped 0.31% and 0.35%, respectively.

Cramer also pointed out that the market has stayed resilient even during the collapse of FTX. The cryptocurrency exchange once valued at $32 billion filed for bankruptcy last week. 

While there are several reasons the market was able to shrug off the crypto disaster, the most important one is rooted in investors’ weariness, he said. “Nobody cares about crypto because we’ve already been in a bear market for a year.”

Cramer added that this mentality extends to investor sentiment towards the broader market.

“Wall Street gets used to the weakness. As a matter of fact, I think we actually become numb to it as long as we’re not dealing with systemic risk,” he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More
Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war
Business

Toyota, Hyundai and Chinese automakers expected to be most impacted by Iran war

Toyota Motor Corp. vehicles bound for shipment at the Port of Nagoya in Tokai, Aichi Prefecture, Japan, on Tuesday, April 29, 2025. Toru Hanai | Bloomberg | Getty Images DETROIT — Toyota Motor, Hyundai Motor and Chinese automakers such as Chery face the most potential impact of non-domestic automakers from the U.S.-Israel war with Iran, […]

Read More